34 For ease of clinical practice application, the AGS provides a pocket card and an app, for a fee, available at To encourage engagement and conversation, AGS provides patient and caregiver educational resources that are available for free at The AGS Beers Criteria lists medications and medication classes that the society and its geriatric expert panel consider potentially inappropriate for use in older adults
Realistic Expectations: Understand that results take time, and complete whitening or dramatic changes may not be feasible for everyone
Our focus on high-quality, science-backed ingredients ensures you receive optimal benefits
Personalization is the core of what we do
Riverstone Wellness reviews side effects with you at every weekly visit so small issues do not become big ones

Key Comparative Insight Mounjaro generally delivers greater average weight loss (around ~23%) compared to Wegovys ~18% at current doses, but Wegovys upcoming 7.2 mg dose may match or even exceed that, with early trial data showing ~21% loss, and a third of patients losing more than 25% Pricing: UK Private Market Spotlight Mounjaro As of 1 September 2025 , UK private prices for the highest dose surged from ~122 to between 270330 per month , a dramatic increase of up to 170% Wegovy Remains considerably more affordable , with private monthly fees typically ranging between 85240 , depending on dose and provider Novo Nordisk has confirmed no planned price increases in the UK Switching: Tips for a Seamless Transition Dosage Alignment : Healthcare providers can match your current Mounjaro dose to an equivalent Wegovy dose (e.g., if you experienced side effects on Mounjaro, they may advise stepping down slightly on Wegovy initially) Avoiding Dual Use : Never take both medications simultaneously doing so increases side effect risks without improving results
